Rallybio PEG Ratio

Rallybio (RLYB) currently reports a PEG ratio of -0.39. That is below the Healthcare sector average of 4.07. Use the charts on this page to explore Rallybio's PEG ratio history and peer comparisons.

Rallybio's PEG ratio of -0.39 is lower than the Healthcare sector average of 4.07. That is roughly 109.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Rallybio's market price to a fundamental measure such as earnings, sales, or book value. At -0.39, RLYB can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -0.39, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 4.07. From there, open related valuation or income-statement pages for Rallybio, and consider following RLYB for alerts when major investors trade the stock.

Rallybio is classified in the Healthcare sector. On PEG ratio, it currently shows -0.39 versus a sector average near 4.07. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RLYB with unrelated industries.